$WMT

Walmart Inc. (WMT) shares rose 3.5% due to sector rotation into defensive stocks amid higher inflation and new U.S. employee health benefits. The company added a zero-dollar prescription tier for associates, covering 250+ medications. Analysts and investors noted the move as part of a broader defensive rotation, not company-specific news.

State Street launched four sector ETFs (XLKM, XLYM, XLPM, XLEM) giving full weight to largest companies. Each holds a Select Sector counterpart and buys extra shares of top firms. Fees are 0.12% annually. Key holdings include Nvidia (NVDA), Amazon (AMZN), Walmart (WMT), and Exxon (XOM).

Walmart (WMT) shares rose 3% to $115.10 after a hotter-than-expected inflation report boosted demand for defensive stocks. Costco (COST) and Target (TGT) also gained. Walmart reported Q2 FY2027 adjusted EPS of $0.81 and raised full-year guidance. Costco's Q4 FY2026 comparable sales rose 9.4%, and Target's YTD stock gain is 61%.

Walmart Inc. (WMT) shares rose 2.71% to $115.32 on Wednesday, benefiting from investor preference for consumer staples amid a broader market decline. The company announced plans to offer over 250 free prescription drugs to employees, including brands like Ozempic and Mounjaro, to attract and retain workers. Other retailers like Costco and Target also saw gains.

Walmart opened its fifth 900,000-square-foot fulfillment center in California, featuring automation and machine learning to improve shipping speed and efficiency. The facility reduces the fulfillment process to five steps, enhancing storage capacity and order fulfillment rates. This expansion supports Walmart's goal of reaching 95% of the U.S. population with next- or two-day shipping and will also service third-party Marketplace items.

Conagra Brands (CAG) has discontinued its Celeste frozen pizza line, sold at retailers like Walmart (WMT) and Tops Friendly Markets. The decision, announced during the company's fiscal 2027 Q1 earnings call, aims to simplify its portfolio and focus on brands with greater growth potential, according to CEO John Brase.

Moody's upgraded its outlook for global retail and apparel to stable, citing easing tariffs and stable labor markets. It forecasts 2-4% revenue growth and 0-2% adjusted EBIT growth over 12-18 months. Tariff refunds may offset higher costs, but uneven demand and geopolitical risks persist. Discounters like Walmart and Target may benefit, while home improvement sectors face tepid growth.

The FDA sent warning letters to Amazon and Walmart over unapproved genital herpes products sold on their sites, citing public health risks. The products, including FemiClear and HerpCare, claim to treat herpes but lack FDA approval. Both companies have 15 days to respond. Genital herpes has no cure, but prescription medicines can manage symptoms and reduce transmission.

Walmart is integrating AI to improve inventory management, customer service, and operations. CEO John Furner highlighted AI's role in enhancing shopping experiences and employee efficiency during the Q2 2027 earnings call. The company also partners with AI platforms like ChatGPT and Gemini, which drive repeat customer behavior. Walmart aims to combine physical and digital assets for a connected retail experience, though profitability and efficiency gains remain uncertain.

Bank of America analysts observed changes at Walmart, Target, and Dollar General aimed at enhancing the shopping experience. Walmart introduced digital shelf labels with flashing lights to help customers locate items. Target is focusing on popular merchandise like Pokémon to attract shoppers. Dollar General is expanding its $1 merchandise and improving store layout. These changes reflect a broader shift in retail to offer more value beyond low prices.